Study evaluates tools for assessing atrial fibrillation bleeding risk

09/19/2013 | Healio

The HAS-BLED bleeding risk score may be superior to two other scores in predicting major bleeding in patients with atrial fibrillation who have been treated with anticoagulants, according to a study in the Journal of the American College of Cardiology. However, researchers stressed that HAS-BLED was not meant to forecast thromboembolitic events, and they noted that providers should use the CHADS2 and CHA2DS2-VASc scores for that.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ